JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
NBRAX
Price
$27.12
Change
-$0.10 (-0.37%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs NBRAX

Header iconJVMTX vs NBRAX Comparison
Open Charts JVMTX vs NBRAXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Neuberger Berman M/C Intrinsic Val A
Price$27.12
Change-$0.10 (-0.37%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs NBRAX Comparison Chart
Loading...
VS
JVMTX vs. NBRAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and NBRAX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. NBRAX (56.4M). JVMTX pays higher dividends than NBRAX: JVMTX (0.73) vs NBRAX (0.40). JVMTX was incepted earlier than NBRAX: JVMTX (11 years) vs NBRAX (14 years). JVMTX is a more actively managed with annual turnover of: 41.00 vs. NBRAX (15.00). JVMTX has a lower initial minimum investment than NBRAX: JVMTX (0) vs NBRAX (1000). JVMTX annual gain was more profitable for investors over the last year : 19.27 vs. NBRAX (16.82). JVMTX return over 5 years is better than : 43.64 vs. NBRAX (35.79).
JVMTXNBRAXJVMTX / NBRAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years14 years-
Gain YTD11.0106.578167%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B56.4M41,489%
Annual Yield % from dividends0.730.40182%
Returns for 1 year19.2716.82115%
Returns for 3 years13.3815.7685%
Returns for 5 years43.6435.79122%
Returns for 10 years63.3415.06421%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems